Initial studies indicated that an increased p53 expression in Aβ treated cultured neurons and high amyloid precursor protein (APP) in glioma cells are two observations that drive the commonalities between the two disease types [100,101]. The gene discussed is TP53; the disease is central nervous system cancer.